Adequan® Canine (polysulfated glycosaminoglycan) is the only FDA-approved
disease-modifying osteoarthritis drug (DMOAD) that inhibits cartilage loss in the dog's joints, and may help to:1
- Restore joint lubrication
- Relieve inflammation
- Renew the building blocks of healthy cartilage
That’s what makes Adequan® Canine different from a supplement or NSAID. It proactively treats the disease and not just the signs of canine osteoarthritis.1
The specific mechanism of action of Adequan® in canine joints is not known.1